Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Cancer|May 19, 2012
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trialAndrew J Wagner, John M Goldberg, Steven G Dubois, et al.
Annals of Surgical Oncology|March 5, 2009
Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomasUgwuji N Maduekwe, Francis J Hornicek, Dempsey S Springfield, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomasWalter Banfield, Myrsini Ioakeim-Ioannidou, Saveli Goldberg, et al.
Advances in Radiation Oncology|July 26, 2017
Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomasThomas F DeLaney, Yen-Lin Chen, Elizabeth H Baldini, et al.
Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.
Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Sujana Movva, Sahar Matloob, Elizabeth A Handorf, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Pageof 18